Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Present and future of acyclovir.

J M Yeo, A P Fiddian

    Scandinavian Journal of Infectious Diseases. Supplementum
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Acyclovir effectively treats common herpes virus infections. Ongoing research evaluates its use against cytomegalovirus (CMV) and Epstein-Barr virus (EBV), with promising developments in acyclovir analogues for improved antiviral therapy.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Depolarization vs. repolarization: what is the mechanism of ventricular arrhythmogenesis underlying sodium channel haploinsufficiency in mouse hearts?

    Acta physiologica (Oxford, England)·2016
    Same author

    Bare below the elbows: was the target the white coat?

    The Journal of hospital infection·2015
    Same author

    Effects of Cordyceps militaris on the growth of rumen microorganisms and in vitro rumen fermentation with respect to methane emissions.

    Journal of dairy science·2014
    Same author

    A curious case of unilateral spider nevi, cirrhosis and stroke: unilateral nevoid telangiectasia syndrome.

    The journal of the Royal College of Physicians of Edinburgh·2013
    Same author

    Effect of feeding high-temperature, microtime-treated diets with different lipid sources on conjugated linoleic acid formation in finishing Hanwoo steers.

    Journal of animal science·2008
    Same author

    Effects of dietary amino acid balance on the response of dairy cows to an increase of milking frequency from twice to three times daily.

    Journal of dairy science·2003
    Same journal

    Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.

    Scandinavian journal of infectious diseases. Supplementum·2009
    Same journal

    Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.

    Scandinavian journal of infectious diseases. Supplementum·2009
    Same journal

    Supreme Court decision on genotypic tests for antiretroviral drugs resistance: Joint Criminal Divisions.

    Scandinavian journal of infectious diseases. Supplementum·2004
    Same journal

    Brief summary of the legal proceeding.

    Scandinavian journal of infectious diseases. Supplementum·2004
    Same journal

    Too early or too late: a never-ending dilemma with new technologies.

    Scandinavian journal of infectious diseases. Supplementum·2004
    Same journal

    Genotypic resistance tests for the management of postexposure prophylaxis.

    Scandinavian journal of infectious diseases. Supplementum·2004
    See all related articles

    Area of Science:

    • Virology
    • Pharmacology
    • Infectious Diseases

    Background:

    • Acyclovir is a recognized treatment for herpes virus infections.
    • Continued evaluation is necessary for specific viral infections.

    Purpose of the Study:

    • To assess acyclovir's efficacy in cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections.
    • To explore the potential of novel acyclovir analogues.

    Main Methods:

    • Clinical evaluation of acyclovir.
    • Pharmacokinetic and antiviral activity assessments of drug analogues.

    Main Results:

    • Acyclovir is established for common herpes virus management.
    • Ongoing studies focus on CMV and EBV treatment efficacy.

    Conclusions:

    • Acyclovir is a well-tolerated and effective antiviral agent.
    • Future antiviral therapies show promise with acyclovir analogue development.